Variant report
Variant | nsv971143 |
---|---|
Chromosome Location | chr7:109621104-109636249 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75620012 | chr7:109621147-109621148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184381591 | chr7:109621166-109621167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2523216 | chr7:109621200-109621201 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs112428739 | chr7:109621235-109621236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75981615 | chr7:109621236-109621237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550823543 | chr7:109621243-109621244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2523217 | chr7:109621244-109621245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189211380 | chr7:109621245-109621246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116897939 | chr7:109621257-109621258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34550942 | chr7:109621271-109621272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566566668 | chr7:109621272-109621273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112960925 | chr7:109621280-109621281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555188827 | chr7:109621286-109621287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181883275 | chr7:109621298-109621299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532686431 | chr7:109621300-109621301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557619346 | chr7:109621347-109621348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73433535 | chr7:109621350-109621351 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs148182950 | chr7:109621363-109621364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140238740 | chr7:109621370-109621371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184927883 | chr7:109621383-109621384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73195871 | chr7:109621418-109621419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562061722 | chr7:109621511-109621512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191196007 | chr7:109621561-109621562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150323449 | chr7:109621609-109621610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550534893 | chr7:109621677-109621678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564360247 | chr7:109621777-109621778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533309689 | chr7:109621791-109621792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138439613 | chr7:109621797-109621798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181277564 | chr7:109621807-109621808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374148474 | chr7:109621815-109621816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73716023 | chr7:109621823-109621824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs115234694 | chr7:109621838-109621839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186696609 | chr7:109621842-109621843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12113923 | chr7:109621848-109621849 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs557180953 | chr7:109621896-109621897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191520195 | chr7:109621901-109621902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539703597 | chr7:109621940-109621941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553266168 | chr7:109621979-109621980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2523218 | chr7:109622028-109622029 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs541885384 | chr7:109622098-109622099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562192694 | chr7:109622106-109622107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559785151 | chr7:109622161-109622162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575686461 | chr7:109622168-109622169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544390147 | chr7:109622218-109622219 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs36014566 | chr7:109622232-109622233 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564225034 | chr7:109622238-109622239 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533179447 | chr7:109622288-109622289 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546890859 | chr7:109622299-109622300 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560473291 | chr7:109622359-109622360 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528867800 | chr7:109622376-109622377 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:109620600-109621200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr7:109620800-109621200 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr7:109620800-109621200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr7:109620800-109621400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr7:109621000-109621400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr7:109621200-109622200 | Weak transcription | H1 Cell Line | embryonic stem cell |
7 | chr7:109621200-109622200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr7:109622200-109622600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
9 | chr7:109622200-109622600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr7:109622200-109622800 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
11 | chr7:109622800-109623200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr7:109623200-109623400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr7:109624800-109625200 | Enhancers | NHEK | skin |
14 | chr7:109624800-109625400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr7:109626400-109627200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr7:109626600-109627000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr7:109627600-109628800 | Enhancers | Fetal Heart | heart |
18 | chr7:109635600-109636000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr7:109635600-109636200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |